Your session is about to expire
← Back to Search
Serum Phosphate Targets for Hemodialysis Patients
Study Summary
This trial is testing the hypothesis that less stringent control of serum phosphate will result in improved outcomes for patients with ESRD undergoing hemodialysis.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 3 trial • 51 Patients • NCT03740048Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are pregnant.You need to stay overnight at the hospital for the study.You have calciphylaxis.
- Group 1: Hi Arm
- Group 2: Lo Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many subjects are enrolled in this medical trial?
"A total of 4400 eligible patients must be enrolled in this pharmaceutical trial to complete the research. This initiative is being managed by Davita Clinical Research with sites located in Hastings, Illinois and Glencoe, North dakota."
Are enrollment opportunities for this experiment still available?
"Affirmative. According to clinicaltrials.gov, this experiment is actively recruiting patients who meet the criteria. First posted on March 13th 2020 and last updated on November 10th 2022, it needs 4400 participants from 39 sites across the country."
How many facilities are responsible for overseeing this clinical trial?
"This clinical research is recruiting from 39 different medical sites, including DaVita Historical Hastings in Hastings, DaVita Glencoe in Glencoe and DaVita East Valley in Apple Valley."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger